Share on StockTwits

PhotoMedex (NASDAQ:PHMD) will announce its earnings results on Monday, May 12th. Investors interested in registering for the company’s conference call can do so using this link.

PhotoMedex (NASDAQ:PHMD) last announced its earnings results on Thursday, March 13th. The company reported $0.28 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.27 by $0.01. The company had revenue of $63.50 million for the quarter, compared to the consensus estimate of $57.17 million. The company’s quarterly revenue was up 15.9% on a year-over-year basis. On average, analysts expect PhotoMedex to post $1.03 EPS for the current fiscal year and $1.19 EPS for the next fiscal year.

Shares of PhotoMedex (NASDAQ:PHMD) opened at 13.48 on Friday. PhotoMedex has a 52-week low of $10.51 and a 52-week high of $17.05. The stock has a 50-day moving average of $15.16 and a 200-day moving average of $13.92. The company has a market cap of $252.3 million and a P/E ratio of 15.93.

Several analysts have recently commented on the stock. Analysts at TheStreet upgraded shares of PhotoMedex from a “hold” rating to a “buy” rating in a research note on Monday, March 17th. On the ratings front, analysts at Maxim Group raised their price target on shares of PhotoMedex from $17.00 to $20.00 in a research note on Friday, March 14th. They now have a “buy” rating on the stock. Finally, analysts at Ascendiant Capital Markets downgraded shares of PhotoMedex from a “strong-buy” rating to a “buy” rating in a research note on Friday, March 14th. They now have a $2.00 price target on the stock, down previously from $18.00. They noted that the move was a valuation call. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $13.23.

PhotoMedex, Inc (NASDAQ:PHMD) is a Global Skin Health Solutions company that provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.